[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Nuclear Medicine Radioisotopes Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

January 2021 | 100 pages | ID: N85D0B4C8668EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Nuclear Medicine Radioisotopes market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Nuclear Medicine Radioisotopes market segmented into
  • Thallium-201 (Tl-201)
  • Iodine (I-123)
  • Fluorine-18
  • Rubidium-82 (Rb-82)
  • Others
Based on the end-use, the global Nuclear Medicine Radioisotopes market classified into
  • Tumor
  • Heart Disease
  • Lymphoma
  • Thyroid Gland
  • Others
Based on geography, the global Nuclear Medicine Radioisotopes market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Agfa-Gevaert Group
  • Braco
  • Cardiarc
  • Cardinal Health
  • CMR Naviscan (Gamma Medica Inc.)
  • Curium
  • Digirad
  • GE Healthcare
  • Nordion (Canada)
  • NTP Radioisotopes SOC
  • Positron
  • Segami
  • Siemens Healthcare
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL NUCLEAR MEDICINE RADIOISOTOPES INDUSTRY

2.1 Summary about Nuclear Medicine Radioisotopes Industry
2.2 Nuclear Medicine Radioisotopes Market Trends
  2.2.1 Nuclear Medicine Radioisotopes Production & Consumption Trends
  2.2.2 Nuclear Medicine Radioisotopes Demand Structure Trends
2.3 Nuclear Medicine Radioisotopes Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Thallium-201 (Tl-201)
  4.2.2 Iodine (I-123)
  4.2.3 Fluorine-18
  4.2.4 Rubidium-82 (Rb-82)
  4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Tumor
  4.3.2 Heart Disease
  4.3.3 Lymphoma
  4.3.4 Thyroid Gland
  4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Thallium-201 (Tl-201)
  5.2.2 Iodine (I-123)
  5.2.3 Fluorine-18
  5.2.4 Rubidium-82 (Rb-82)
  5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Tumor
  5.3.2 Heart Disease
  5.3.3 Lymphoma
  5.3.4 Thyroid Gland
  5.3.5 Others
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Thallium-201 (Tl-201)
  6.2.2 Iodine (I-123)
  6.2.3 Fluorine-18
  6.2.4 Rubidium-82 (Rb-82)
  6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Tumor
  6.3.2 Heart Disease
  6.3.3 Lymphoma
  6.3.4 Thyroid Gland
  6.3.5 Others
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Thallium-201 (Tl-201)
  7.2.2 Iodine (I-123)
  7.2.3 Fluorine-18
  7.2.4 Rubidium-82 (Rb-82)
  7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Tumor
  7.3.2 Heart Disease
  7.3.3 Lymphoma
  7.3.4 Thyroid Gland
  7.3.5 Others
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Thallium-201 (Tl-201)
  8.2.2 Iodine (I-123)
  8.2.3 Fluorine-18
  8.2.4 Rubidium-82 (Rb-82)
  8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Tumor
  8.3.2 Heart Disease
  8.3.3 Lymphoma
  8.3.4 Thyroid Gland
  8.3.5 Others
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Thallium-201 (Tl-201)
  9.2.2 Iodine (I-123)
  9.2.3 Fluorine-18
  9.2.4 Rubidium-82 (Rb-82)
  9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Tumor
  9.3.2 Heart Disease
  9.3.3 Lymphoma
  9.3.4 Thyroid Gland
  9.3.5 Others
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Agfa-Gevaert Group
  10.1.2 Braco
  10.1.3 Cardiarc
  10.1.4 Cardinal Health
  10.1.5 CMR Naviscan (Gamma Medica Inc.)
  10.1.6 Curium
  10.1.7 Digirad
  10.1.8 GE Healthcare
  10.1.9 Nordion (Canada)
  10.1.10 NTP Radioisotopes SOC
  10.1.11 Positron
  10.1.12 Segami
  10.1.13 Siemens Healthcare
10.2 Nuclear Medicine Radioisotopes Sales Date of Major Players (2017-2020e)
  10.2.1 Agfa-Gevaert Group
  10.2.2 Braco
  10.2.3 Cardiarc
  10.2.4 Cardinal Health
  10.2.5 CMR Naviscan (Gamma Medica Inc.)
  10.2.6 Curium
  10.2.7 Digirad
  10.2.8 GE Healthcare
  10.2.9 Nordion (Canada)
  10.2.10 NTP Radioisotopes SOC
  10.2.11 Positron
  10.2.12 Segami
  10.2.13 Siemens Healthcare
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Nuclear Medicine Radioisotopes Product Type Overview
2.Table Nuclear Medicine Radioisotopes Product Type Market Share List
3.Table Nuclear Medicine Radioisotopes Product Type of Major Players
4.Table Brief Introduction of Agfa-Gevaert Group
5.Table Brief Introduction of Braco
6.Table Brief Introduction of Cardiarc
7.Table Brief Introduction of Cardinal Health
8.Table Brief Introduction of CMR Naviscan (Gamma Medica Inc.)
9.Table Brief Introduction of Curium
10.Table Brief Introduction of Digirad
11.Table Brief Introduction of GE Healthcare
12.Table Brief Introduction of Nordion (Canada)
13.Table Brief Introduction of NTP Radioisotopes SOC
14.Table Brief Introduction of Positron
15.Table Brief Introduction of Segami
16.Table Brief Introduction of Siemens Healthcare
17.Table Products & Services of Agfa-Gevaert Group
18.Table Products & Services of Braco
19.Table Products & Services of Cardiarc
20.Table Products & Services of Cardinal Health
21.Table Products & Services of CMR Naviscan (Gamma Medica Inc.)
22.Table Products & Services of Curium
23.Table Products & Services of Digirad
24.Table Products & Services of GE Healthcare
25.Table Products & Services of Nordion (Canada)
26.Table Products & Services of NTP Radioisotopes SOC
27.Table Products & Services of Positron
28.Table Products & Services of Segami
29.Table Products & Services of Siemens Healthcare
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Nuclear Medicine Radioisotopes Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Nuclear Medicine Radioisotopes Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Nuclear Medicine Radioisotopes Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Nuclear Medicine Radioisotopes Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Nuclear Medicine Radioisotopes Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Nuclear Medicine Radioisotopes Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Nuclear Medicine Radioisotopes Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Nuclear Medicine Radioisotopes Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Nuclear Medicine Radioisotopes Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Nuclear Medicine Radioisotopes Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Nuclear Medicine Radioisotopes Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Thallium-201 (Tl-201) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Iodine (I-123) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Fluorine-18 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Rubidium-82 (Rb-82) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Heart Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Thyroid Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Thallium-201 (Tl-201) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Iodine (I-123) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Fluorine-18 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Rubidium-82 (Rb-82) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Heart Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Thyroid Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Thallium-201 (Tl-201) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Iodine (I-123) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Fluorine-18 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Rubidium-82 (Rb-82) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Heart Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Thyroid Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Thallium-201 (Tl-201) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Iodine (I-123) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Fluorine-18 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Rubidium-82 (Rb-82) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Heart Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Thyroid Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Thallium-201 (Tl-201) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Iodine (I-123) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Fluorine-18 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rubidium-82 (Rb-82) Seg


More Publications